Form 6-K Telix Pharmaceuticals For: Nov 19
Telix Pharmaceuticals Limited - American Depositary Shares (TLX)
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
TLX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TLX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TLX alerts
High impacting Telix Pharmaceuticals Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TLX
News
- Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation CompleteGlobeNewswire
- Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation CompletePR Newswire
- Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation CompletePR Newswire
- First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese PatientsPR Newswire
- Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ: TLX) was upgraded by analysts at William Blair to a "strong-buy" rating.MarketBeat
TLX
Sec Filings
- 12/19/24 - Form S-8
- 12/11/24 - Form SEC
- 12/11/24 - Form SEC
- TLX's page on the SEC website